Resultados de la búsqueda 1151-1160 of 4575 for Blood factor II

  1. Oncología (médica) - Ensayos clínicos

    Blood And Urine Identification Of Methylated DNA ... In the phase II part, to evaluate the preliminary antitumor activity of two ... The study has 2 Modules: Module ...

  2. Ataque cardíaco - Médicos y departamentos - Mayo Clinic

    ... Blood Health support group on Mayo Clinic Connect, a patient community. Heart & Blood Health Discussions ... Suplementos de calcio: ¿Un factor de riesgo de ataque ...

  3. Oncología (médica) - Ensayos clínicos

    This study is being done to store blood, buccal ... factors that may determine disease progression and treatment response. ... [1, 2] The solid tumor ...

  4. Ensayos clínicos - Medicina pulmonar

    A Study to Collect Medical and Personal Histories, Blood ... This study will also help us to learn whether certain genes (inherited factors ... Ir a página 22 · Ir ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... two lines of therapy as measured by objective ... Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection.

  6. Prueba de presión arterial - Mayo Clinic

    ... 2 a 5 años. ... El peso es un factor de riesgo para la hipertensión arterial. ... https://www.heart.org/en/health-topics/high-blood-pressure/understanding-blood- ...

  7. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...

  8. Oncología (médica) - Ensayos clínicos

    A Blood Collection Protocol to Study the Immune Responses of Cancer Patients with Malignancies ... (2) Cohort 2 focuses on primary or secondary ...

  9. Dermatología - Ensayos clínicos

    ... II). Additinoally, to evaluate the effectiveness ... A Study to Develop a Biorepository of Blood ... Ir a página 22 · Solicite una consulta · Grupos ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory aggressive B- ...